Market Overview

Morgan Stanley Sees Another Solid Year Ahead for Becton, Dickinson and Co.

Related BDX
Becton Dickinson Shares Favorably Valued As It Works To Boost Earnings
7 Biggest Price Target Changes For Friday
My Dividend Growth Portfolio - Q3 2016 Summary (Seeking Alpha)

In a report published Wednesday, Morgan Stanley analyst David R. Lewis reiterated an Equal-Weight rating on Becton, Dickinson and Co. (NYSE: BDX).

In the report, Morgan Stanley noted, “Our more bullish tone into FY14 was driven by multi-year investments that have begun to impact top and bottom line results. We continue to expect modest upside through the year and see additional potential acceleration from generic injectables, diabetes, SG&A leverage, and M&A.”

Becton, Dickinson and Co. closed on Tuesday at $106.01.

Latest Ratings for BDX

Sep 2016CitigroupDowngradesNeutralSell
Aug 2016UBSMaintainsBuy
Jul 2016JefferiesMaintainsBuy

View More Analyst Ratings for BDX
View the Latest Analyst Ratings

Posted-In: David R. Lewis Morgan StanleyAnalyst Color Reiteration Analyst Ratings


Related Articles (BDX)

View Comments and Join the Discussion!